Stoke Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:STOK) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -42.22 M-66.91 M-31.87 M-81.07 M-86.85 M45.59 M -146.82 M Cash from investing activities -1.05 M-76.43 M-45.88 M105.95 M-107.47 M-186.81 M -149.75 M Cash from financing activities 108.11 M1.28 M46.41 M53.01 M131.09 M97.39 M 180.34 M Free cash flow -42.22 M-66.91 M-31.87 M-81.07 M-86.85 M44.91 M -147.69 M

News

Is it a Good Idea to Invest in Stoke Therapeutics Stock Now?

Stoke Therapeutics, Inc. (STOK) Q1 2026 Earnings Call Transcript

Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates

Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Lags Revenue Estimates

Rocket Lab Soars, Leads 14 Onto Today's Premium Stock Screens

Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates

Vertex (VRTX) Moves 8.3% Higher: Will This Strength Last?

Stoke Therapeutics stock hits 52-week high at 39.88 USD

Stoke Therapeutics earnings in focus amid Dravet trial progress

Dianthus Therapeutics, Inc. (DNTH) Stock Jumps 12.0%: Will It Continue to Soar?

We Told You So — These IBD 50 Stocks Dominate This Year

Natural Gas Giant Williams Leads 19 Stocks New To IBD Best Stock Lists